The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Impact of Joining the AMA

The Impact of Joining the AMA

May 31, 2017 • By Kelly Tyrrell

  • Tweet
  • Email
Print-Friendly Version / Save PDF

As Congress grapples with repealing and replacing the Affordable Care Act, MACRA benchmarking already underway and other rapid changes to the American healthcare system, it has never been more important for rheumatologists to make their voices heard.

You Might Also Like
  • Maintain Rheumatology’s Seat at the AMA Table
  • ACR Introduces Prior Authorization & Step Therapy Resolutions at AMA Meeting
  • ACR Delegates Move Rheumatology Concerns Forward at AMA
Also By This Author
  • Ultrasound Can be Useful in Diagnosing Gout

This is why it’s critical ACR members join or renew their membership in the American Medical Association (AMA) this year. To maintain representation in the AMA’s House of Delegates (HOD), the voting and policy-making arm of the organization, at least 1,000 members of the ACR must also be members of the AMA. The AMA will conduct its five-year review this year, and rheumatology is currently falling short, risking its seat at the table.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Making AMA Membership a Priority
“There couldn’t be a more important time to be involved,” says Colin Edgerton, MD, FACP, one of the ACR’s two delegates to the AMA and a South Carolina-based rheumatologist who has successfully encouraged nearly all of the 30 physicians in his practice to renew their AMA memberships or become new members. “Physicians need to take a leadership role and hold onto it, because we are best positioned to guide decisions for the benefit of patients and to maintain access to care.”

The ACR and its members do important work, Dr. Edgerton says, but “the AMA brings a much larger and better connected apparatus to bear on influencing both federal and state governments.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

He echoes ACR President Sharad Lakhanpal, MD, MBBS, who in an article published in March 2017 said, “Rheumatology is a relatively small subspecialty, but the AMA is the country’s largest and most visible physician society. Because we have the ability to help guide the AMA’s direction through seats in its House of Delegates, I like to view the AMA as providing rheumatology with a megaphone to amplify our voice at both federal and state levels.”

As Dr. Edgerton explained in an email to the physicians in his practice, through the AMA, the ACR has helped:

  • Exempt small rheumatology practices from some parts of MACRA;
  • Protect individualized compounding facilities in physicians’ offices from the FDA’s definition of a compounding facility;
  • Block the Medicare Part B demonstration project; and
  • Advance work to prohibit clinical data blocking by electronic health record vendors.

AMA as Scapegoat
From his conversations with colleagues and the commentary he observes on the ACR’s listservs, Dr. Edgerton believes the AMA has become the scapegoat for medicine’s challenges. “Generally, there are things we’re dissatisfied with in medicine, but we lack outlets to vent our displeasure, so the AMA ends up being an easy target for what’s wrong in medicine. As physicians, unfortunately, we tend to circle the wagons and shoot at each other at times.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: AMA House of Delegates (HOD), AMA membership, American Medical Association (AMA)

You Might Also Like:
  • Maintain Rheumatology’s Seat at the AMA Table
  • ACR Introduces Prior Authorization & Step Therapy Resolutions at AMA Meeting
  • ACR Delegates Move Rheumatology Concerns Forward at AMA
  • Why Keep a Seat at the AMA Table?

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)